ID   AT1A1_RAT               Reviewed;        1023 AA.
AC   P06685; Q64609;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1988, sequence version 1.
DT   02-OCT-2024, entry version 229.
DE   RecName: Full=Sodium/potassium-transporting ATPase subunit alpha-1;
DE            Short=Na(+)/K(+) ATPase alpha-1 subunit;
DE            EC=7.2.2.13 {ECO:0000269|PubMed:17939993, ECO:0000269|PubMed:30388404};
DE   AltName: Full=Sodium pump subunit alpha-1;
DE   Flags: Precursor;
GN   Name=Atp1a1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain, and Kidney;
RX   PubMed=3028470; DOI=10.1021/bi00373a001;
RA   Shull G.E., Greeb J., Lingrel J.B.;
RT   "Molecular cloning of three distinct forms of the Na+,K+-ATPase alpha-
RT   subunit from rat brain.";
RL   Biochemistry 25:8125-8132(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=2822682; DOI=10.1093/oxfordjournals.jbchem.a122039;
RA   Hara Y., Urayama O., Kawakami K., Nojima H., Nagamune H., Kojima T.,
RA   Ohta T., Nagano K., Nakao M.;
RT   "Primary structures of two types of alpha-subunit of rat brain Na+,K+,-
RT   ATPase deduced from cDNA sequences.";
RL   J. Biochem. 102:43-58(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2822726; DOI=10.1083/jcb.105.4.1855;
RA   Herrera V.L.M., Emanuel J.R., Ruiz-Opazo N., Levenson R., Nadal-Ginard B.;
RT   "Three differentially expressed Na,K-ATPase alpha subunit isoforms:
RT   structural and functional implications.";
RL   J. Cell Biol. 105:1855-1865(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 157-162; 597-605; 630-647; 662-671 AND 744-773, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 489-533.
RC   TISSUE=Brain;
RX   PubMed=2994074; DOI=10.1073/pnas.82.18.6357;
RA   Schneider J.W., Mercer R.W., Caplan M., Emanuel J.R., Sweadner K.J.,
RA   Benz E.J. Jr., Levenson R.;
RT   "Molecular cloning of rat brain Na,K-ATPase alpha-subunit cDNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:6357-6361(1985).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-41.
RX   PubMed=2166579; DOI=10.1016/0167-4781(90)90099-n;
RA   Yagawa Y., Kawakami K., Nagano K.;
RT   "Cloning and analysis of the 5'-flanking region of rat Na+/K(+)-ATPase
RT   alpha 1 subunit gene.";
RL   Biochim. Biophys. Acta 1049:286-292(1990).
RN   [8]
RP   PHOSPHORYLATION BY CAMP-DEPENDENT KINASE.
RX   PubMed=7510709; DOI=10.1016/s0021-9258(17)37117-x;
RA   Fisone G., Cheng S.X.-J., Nairn A.C., Czernik A.J., Hemmings H.C. Jr.,
RA   Hoeoeg J.-O., Bertorello A.M., Kaiser R., Bergman T., Joernvall H.,
RA   Aperia A., Greengard P.;
RT   "Identification of the phosphorylation site for cAMP-dependent protein
RT   kinase on Na+,K(+)-ATPase and effects of site-directed mutagenesis.";
RL   J. Biol. Chem. 269:9368-9373(1994).
RN   [9]
RP   PHOSPHORYLATION AT SER-23 AND SER-943.
RX   PubMed=9435504; DOI=10.1152/ajpcell.1997.273.6.c1981;
RA   Cheng X.J., Hoeoeg J.O., Nairn A.C., Greengard P., Aperia A.;
RT   "Regulation of rat Na(+)-K(+)-ATPase activity by PKC is modulated by state
RT   of phosphorylation of Ser-943 by PKA.";
RL   Am. J. Physiol. 273:C1981-C1986(1997).
RN   [10]
RP   PHOSPHORYLATION AT TYR-10.
RX   PubMed=10473631; DOI=10.1091/mbc.10.9.2847;
RA   Feraille E., Carranza M.L., Gonin S., Beguin P., Pedemonte C.,
RA   Rousselot M., Caverzasio J., Geering K., Martin P.Y., Favre H.;
RT   "Insulin-induced stimulation of Na+,K(+)-ATPase activity in kidney proximal
RT   tubule cells depends on phosphorylation of the alpha-subunit at Tyr-10.";
RL   Mol. Biol. Cell 10:2847-2859(1999).
RN   [11]
RP   PROTEIN SEQUENCE OF N-TERMINUS, AND PHOSPHORYLATION AT SER-16 AND SER-23 BY
RP   PROTEIN KINASE C.
RX   PubMed=7775468; DOI=10.1074/jbc.270.23.14072;
RA   Feschenko M.S., Sweadner K.J.;
RT   "Structural basis for species-specific differences in the phosphorylation
RT   of Na,K-ATPase by protein kinase C.";
RL   J. Biol. Chem. 270:14072-14077(1995).
RN   [12]
RP   BINDING SITE FOR PHOSPHOINOSITIDE-3 KINASE, AND MUTAGENESIS OF SER-16 AND
RP   PRO-83.
RX   PubMed=10823893; DOI=10.1073/pnas.100128297;
RA   Yudowski G.A., Efendiev R., Pedemonte C.H., Katz A.I., Berggren P.-O.,
RA   Bertorello A.M.;
RT   "Phosphoinositide-3 kinase binds to a proline-rich motif in the Na+, K+-
RT   ATPase alpha subunit and regulates its trafficking.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:6556-6561(2000).
RN   [13]
RP   INTERACTION WITH FXYD3.
RX   PubMed=15743908; DOI=10.1091/mbc.e04-10-0878;
RA   Crambert G., Li C., Claeys D., Geering K.;
RT   "FXYD3 (Mat-8), a new regulator of Na,K-ATPase.";
RL   Mol. Biol. Cell 16:2363-2371(2005).
RN   [14]
RP   INTERACTION WITH FXYD1.
RX   PubMed=17283221; DOI=10.1096/fj.06-7269com;
RA   Pavlovic D., Fuller W., Shattock M.J.;
RT   "The intracellular region of FXYD1 is sufficient to regulate cardiac Na/K
RT   ATPase.";
RL   FASEB J. 21:1539-1546(2007).
RN   [15]
RP   PHOSPHORYLATION, DEPHOSPHORYLATION, INTERACTION WITH SIK1, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=17939993; DOI=10.1073/pnas.0706838104;
RA   Sjostrom M., Stenstrom K., Eneling K., Zwiller J., Katz A.I., Takemori H.,
RA   Bertorello A.M.;
RT   "SIK1 is part of a cell sodium-sensing network that regulates active sodium
RT   transport through a calcium-dependent process.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:16922-16927(2007).
RN   [16]
RP   INTERACTION WITH FXYD1.
RX   PubMed=19339511; DOI=10.1152/ajpcell.00523.2008;
RA   Fuller W., Howie J., McLatchie L.M., Weber R.J., Hastie C.J., Burness K.,
RA   Pavlovic D., Shattock M.J.;
RT   "FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes:
RT   threonine 69 is a novel substrate for protein kinase C.";
RL   Am. J. Physiol. 296:C1346-C1355(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40; SER-47; SER-228; SER-452
RP   AND SER-484, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [18]
RP   INTERACTION WITH FXYD1.
RX   PubMed=23532852; DOI=10.1074/jbc.m113.460956;
RA   Wypijewski K.J., Howie J., Reilly L., Tulloch L.B., Aughton K.L.,
RA   McLatchie L.M., Shattock M.J., Calaghan S.C., Fuller W.;
RT   "A separate pool of cardiac phospholemman that does not regulate or
RT   associate with the sodium pump: multimers of phospholemman in ventricular
RT   muscle.";
RL   J. Biol. Chem. 288:13808-13820(2013).
RN   [19]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=29499166; DOI=10.1016/j.ajhg.2018.01.023;
RA   Lassuthova P., Rebelo A.P., Ravenscroft G., Lamont P.J., Davis M.R.,
RA   Manganelli F., Feely S.M., Bacon C., Brozkova D.S., Haberlova J.,
RA   Mazanec R., Tao F., Saghira C., Abreu L., Courel S., Powell E., Buglo E.,
RA   Bis D.M., Baxter M.F., Ong R.W., Marns L., Lee Y.C., Bai Y., Isom D.G.,
RA   Barro-Soria R., Chung K.W., Scherer S.S., Larsson H.P., Laing N.G.,
RA   Choi B.O., Seeman P., Shy M.E., Santoro L., Zuchner S.;
RT   "Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2.";
RL   Am. J. Hum. Genet. 102:505-514(2018).
RN   [20]
RP   MUTAGENESIS OF LEU-302; GLY-303 AND MET-859, FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=30388404; DOI=10.1016/j.ajhg.2018.10.004;
RA   Schlingmann K.P., Bandulik S., Mammen C., Tarailo-Graovac M., Holm R.,
RA   Baumann M., Koenig J., Lee J.J.Y., Droegemoeller B., Imminger K.,
RA   Beck B.B., Altmueller J., Thiele H., Waldegger S., Van't Hoff W., Kleta R.,
RA   Warth R., van Karnebeek C.D.M., Vilsen B., Bockenhauer D., Konrad M.;
RT   "Germline de novo mutations in ATP1A1 cause renal hypomagnesemia,
RT   refractory seizures, and intellectual disability.";
RL   Am. J. Hum. Genet. 103:808-816(2018).
RN   [21]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF GLU-314.
RX   PubMed=16914892; DOI=10.1159/000095169;
RA   Lerner M., Lemke D., Bertram H., Schillers H., Oberleithner H.,
RA   Caplan M.J., Reinhardt J.;
RT   "An extracellular loop of the human non-gastric H,K-ATPase alpha-subunit is
RT   involved in apical plasma membrane polarization.";
RL   Cell. Physiol. Biochem. 18:75-84(2006).
RN   [22]
RP   STRUCTURE BY NMR OF 383-595 ALONE AND IN COMPLEX WITH ATP, AND ATP-BINDING
RP   SITE.
RX   PubMed=12730684; DOI=10.1038/nsb924;
RA   Hilge M., Siegal G., Vuister G.W., Guntert P., Gloor S.M., Abrahams J.P.;
RT   "ATP-induced conformational changes of the nucleotide-binding domain of
RT   Na,K-ATPase.";
RL   Nat. Struct. Biol. 10:468-474(2003).
CC   -!- FUNCTION: This is the catalytic component of the active enzyme, which
CC       catalyzes the hydrolysis of ATP coupled with the exchange of sodium and
CC       potassium ions across the plasma membrane. This action creates the
CC       electrochemical gradient of sodium and potassium ions, providing the
CC       energy for active transport of various nutrients (PubMed:30388404).
CC       Could also be part of an osmosensory signaling pathway that senses
CC       body-fluid sodium levels and controls salt intake behavior as well as
CC       voluntary water intake to regulate sodium homeostasis (By similarity).
CC       {ECO:0000250|UniProtKB:Q8VDN2, ECO:0000269|PubMed:30388404}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + K(+)(out) + Na(+)(in) = ADP + H(+) + K(+)(in) +
CC         Na(+)(out) + phosphate; Xref=Rhea:RHEA:18353, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29101, ChEBI:CHEBI:29103,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         EC=7.2.2.13; Evidence={ECO:0000269|PubMed:17939993,
CC         ECO:0000269|PubMed:30388404};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18354;
CC         Evidence={ECO:0000269|PubMed:30388404};
CC   -!- SUBUNIT: The sodium/potassium-transporting ATPase is composed of a
CC       catalytic alpha subunit, an auxiliary non-catalytic beta subunit and an
CC       additional regulatory subunit. Interacts with regulatory subunit FXYD1
CC       (PubMed:17283221, PubMed:19339511, PubMed:23532852). Interacts with
CC       regulatory subunit FXYD3 (PubMed:15743908). Interacts with SLC35G1 and
CC       STIM1 (By similarity). Interacts with SIK1 (PubMed:17939993). Interacts
CC       with CLN3; this interaction regulates the sodium/potassium-transporting
CC       ATPase complex localization at the plasma membrane (By similarity).
CC       Interacts with SCN7A; activates ATP1A1 P-type sodium:potassium-
CC       exchanging transporter activity which indirectly signals to nearby
CC       neurons to regulate sodium homeostasis (By similarity).
CC       {ECO:0000250|UniProtKB:P05023, ECO:0000250|UniProtKB:Q8VDN2,
CC       ECO:0000269|PubMed:15743908, ECO:0000269|PubMed:17283221,
CC       ECO:0000269|PubMed:17939993, ECO:0000269|PubMed:19339511,
CC       ECO:0000269|PubMed:23532852}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q8VDN2};
CC       Multi-pass membrane protein {ECO:0000255}. Basolateral cell membrane
CC       {ECO:0000269|PubMed:16914892}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell membrane, sarcolemma
CC       {ECO:0000250|UniProtKB:P05023}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell projection, axon {ECO:0000269|PubMed:29499166}.
CC       Melanosome {ECO:0000250|UniProtKB:P05023}.
CC   -!- TISSUE SPECIFICITY: Expressed in the central nervous system, in most
CC       motor and sensory axons of the ventral and dorsal roots, as well as in
CC       the large motor neurons of the ventral horn (at protein level).
CC       {ECO:0000269|PubMed:29499166}.
CC   -!- PTM: Phosphorylation on Tyr-10 modulates pumping activity.
CC       Phosphorylation of Ser-943 by PKA modulates the response of ATP1A1 to
CC       PKC. Dephosphorylation by protein phosphatase 2A (PP2A) following
CC       increases in intracellular sodium, leading to increase catalytic
CC       activity. {ECO:0000269|PubMed:10473631, ECO:0000269|PubMed:17939993,
CC       ECO:0000269|PubMed:7510709, ECO:0000269|PubMed:7775468,
CC       ECO:0000269|PubMed:9435504}.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type) (TC 3.A.3)
CC       family. Type IIC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M14511; AAA40775.1; -; mRNA.
DR   EMBL; X05882; CAA29306.1; -; mRNA.
DR   EMBL; M28647; AAA41671.1; -; mRNA.
DR   EMBL; BC061968; AAH61968.1; -; mRNA.
DR   EMBL; M11733; AAA40783.1; -; mRNA.
DR   EMBL; X53233; CAA37325.1; -; Genomic_DNA.
DR   EMBL; X53234; CAA37326.1; -; Genomic_DNA.
DR   PIR; A24639; A24639.
DR   RefSeq; NP_036636.1; NM_012504.1.
DR   PDB; 1MO7; NMR; -; A=386-595.
DR   PDB; 1MO8; NMR; -; A=386-595.
DR   PDBsum; 1MO7; -.
DR   PDBsum; 1MO8; -.
DR   AlphaFoldDB; P06685; -.
DR   BMRB; P06685; -.
DR   SMR; P06685; -.
DR   BioGRID; 246399; 19.
DR   ELM; P06685; -.
DR   IntAct; P06685; 7.
DR   MINT; P06685; -.
DR   STRING; 10116.ENSRNOP00000045650; -.
DR   BindingDB; P06685; -.
DR   ChEMBL; CHEMBL3010; -.
DR   DrugCentral; P06685; -.
DR   GlyGen; P06685; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P06685; -.
DR   PhosphoSitePlus; P06685; -.
DR   jPOST; P06685; -.
DR   PaxDb; 10116-ENSRNOP00000045650; -.
DR   Ensembl; ENSRNOT00000040430.5; ENSRNOP00000045650.4; ENSRNOG00000030019.5.
DR   Ensembl; ENSRNOT00055033788; ENSRNOP00055027434; ENSRNOG00055019753.
DR   Ensembl; ENSRNOT00060049314; ENSRNOP00060041161; ENSRNOG00060028283.
DR   Ensembl; ENSRNOT00065051454; ENSRNOP00065042372; ENSRNOG00065029722.
DR   GeneID; 24211; -.
DR   KEGG; rno:24211; -.
DR   UCSC; RGD:2167; rat.
DR   AGR; RGD:2167; -.
DR   CTD; 476; -.
DR   RGD; 2167; Atp1a1.
DR   eggNOG; KOG0203; Eukaryota.
DR   GeneTree; ENSGT00940000154840; -.
DR   HOGENOM; CLU_002360_3_0_1; -.
DR   InParanoid; P06685; -.
DR   OrthoDB; 203629at2759; -.
DR   PhylomeDB; P06685; -.
DR   Reactome; R-RNO-5578775; Ion homeostasis.
DR   Reactome; R-RNO-936837; Ion transport by P-type ATPases.
DR   SABIO-RK; P06685; -.
DR   EvolutionaryTrace; P06685; -.
DR   PRO; PR:P06685; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000030019; Expressed in kidney and 20 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0016323; C:basolateral plasma membrane; IMP:UniProtKB.
DR   GO; GO:0005901; C:caveola; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0005768; C:endosome; IDA:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:BHF-UCL.
DR   GO; GO:0014704; C:intercalated disc; IDA:BHF-UCL.
DR   GO; GO:0016328; C:lateral plasma membrane; ISO:RGD.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:ARUK-UCL.
DR   GO; GO:0031090; C:organelle membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0042383; C:sarcolemma; IDA:BHF-UCL.
DR   GO; GO:0005890; C:sodium:potassium-exchanging ATPase complex; IDA:ARUK-UCL.
DR   GO; GO:0036126; C:sperm flagellum; ISO:RGD.
DR   GO; GO:0030315; C:T-tubule; IDA:BHF-UCL.
DR   GO; GO:0043531; F:ADP binding; IDA:RGD.
DR   GO; GO:0030506; F:ankyrin binding; IPI:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IDA:BHF-UCL.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0008556; F:P-type potassium transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0005391; F:P-type sodium:potassium-exchanging transporter activity; IDA:UniProtKB.
DR   GO; GO:0016791; F:phosphatase activity; ISO:RGD.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; IPI:RGD.
DR   GO; GO:0030955; F:potassium ion binding; IDA:BHF-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:ARUK-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0051087; F:protein-folding chaperone binding; IDA:BHF-UCL.
DR   GO; GO:0031402; F:sodium ion binding; IDA:RGD.
DR   GO; GO:1990239; F:steroid hormone binding; ISO:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; ISO:RGD.
DR   GO; GO:0060048; P:cardiac muscle contraction; TAS:BHF-UCL.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IDA:RGD.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; ISO:RGD.
DR   GO; GO:0015988; P:energy coupled proton transmembrane transport, against electrochemical gradient; TAS:RGD.
DR   GO; GO:0010248; P:establishment or maintenance of transmembrane electrochemical gradient; IC:BHF-UCL.
DR   GO; GO:0060047; P:heart contraction; ISO:RGD.
DR   GO; GO:0030007; P:intracellular potassium ion homeostasis; ISO:RGD.
DR   GO; GO:0006883; P:intracellular sodium ion homeostasis; ISO:RGD.
DR   GO; GO:0060081; P:membrane hyperpolarization; IMP:RGD.
DR   GO; GO:0086009; P:membrane repolarization; ISO:RGD.
DR   GO; GO:0031947; P:negative regulation of glucocorticoid biosynthetic process; ISO:RGD.
DR   GO; GO:0045822; P:negative regulation of heart contraction; ISO:RGD.
DR   GO; GO:0007231; P:osmosensory signaling pathway; ISO:RGD.
DR   GO; GO:0045823; P:positive regulation of heart contraction; ISO:RGD.
DR   GO; GO:0045989; P:positive regulation of striated muscle contraction; ISO:RGD.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0006813; P:potassium ion transport; IDA:RGD.
DR   GO; GO:1902600; P:proton transmembrane transport; IBA:GO_Central.
DR   GO; GO:0008217; P:regulation of blood pressure; ISO:RGD.
DR   GO; GO:0086004; P:regulation of cardiac muscle cell contraction; IMP:RGD.
DR   GO; GO:0002028; P:regulation of sodium ion transport; IDA:UniProtKB.
DR   GO; GO:0002026; P:regulation of the force of heart contraction; ISO:RGD.
DR   GO; GO:0055119; P:relaxation of cardiac muscle; TAS:BHF-UCL.
DR   GO; GO:1903416; P:response to glycoside; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0036376; P:sodium ion export across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0055078; P:sodium ion homeostasis; ISO:RGD.
DR   GO; GO:0006814; P:sodium ion transport; IDA:RGD.
DR   GO; GO:0055085; P:transmembrane transport; IDA:BHF-UCL.
DR   CDD; cd02608; P-type_ATPase_Na-K_like; 1.
DR   Gene3D; 3.40.1110.10; Calcium-transporting ATPase, cytoplasmic domain N; 1.
DR   Gene3D; 2.70.150.10; Calcium-transporting ATPase, cytoplasmic transduction domain A; 1.
DR   Gene3D; 1.20.1110.10; Calcium-transporting ATPase, transmembrane domain; 1.
DR   Gene3D; 3.40.50.1000; HAD superfamily/HAD-like; 1.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_dom_N.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom_sf.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A_sf.
DR   InterPro; IPR050510; Cation_transp_ATPase_P-type.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR005775; P-type_ATPase_IIC.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR044492; P_typ_ATPase_HD_dom.
DR   NCBIfam; TIGR01106; ATPase-IIC_X-K; 1.
DR   NCBIfam; TIGR01494; ATPase_P-type; 2.
DR   PANTHER; PTHR43294; SODIUM/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA; 1.
DR   PANTHER; PTHR43294:SF9; SODIUM_POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA-1; 1.
DR   Pfam; PF13246; Cation_ATPase; 1.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 1.
DR   PRINTS; PR00119; CATATPASE.
DR   PRINTS; PR00121; NAKATPASE.
DR   SFLD; SFLDS00003; Haloacid_Dehalogenase; 1.
DR   SFLD; SFLDF00027; p-type_atpase; 1.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF81653; Calcium ATPase, transduction domain A; 1.
DR   SUPFAM; SSF81665; Calcium ATPase, transmembrane domain M; 1.
DR   SUPFAM; SSF56784; HAD-like; 1.
DR   SUPFAM; SSF81660; Metal cation-transporting ATPase, ATP-binding domain N; 1.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cell membrane; Cell projection;
KW   Direct protein sequencing; Ion transport; Magnesium; Membrane;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Potassium;
KW   Potassium transport; Reference proteome; Sodium; Sodium transport;
KW   Sodium/potassium transport; Translocase; Transmembrane;
KW   Transmembrane helix; Transport.
FT   PROPEP          1..5
FT                   /evidence="ECO:0000269|PubMed:7775468"
FT                   /id="PRO_0000002489"
FT   CHAIN           6..1023
FT                   /note="Sodium/potassium-transporting ATPase subunit alpha-
FT                   1"
FT                   /id="PRO_0000002490"
FT   TOPO_DOM        6..87
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        88..108
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        109..131
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        132..152
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        153..288
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        289..308
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        309..320
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        321..338
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        339..772
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        773..792
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        793..802
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        803..823
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        824..843
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        844..866
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        867..918
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        919..938
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        939..951
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        952..970
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        971..985
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        986..1006
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1007..1023
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..38
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          82..84
FT                   /note="Phosphoinositide-3 kinase binding"
FT   REGION          216..235
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          596..717
FT                   /note="Mediates interaction with SCN7A"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDN2"
FT   ACT_SITE        376
FT                   /note="4-aspartylphosphate intermediate"
FT                   /evidence="ECO:0000250"
FT   BINDING         487
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:12730684"
FT   BINDING         717
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         721
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         9
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDN2"
FT   MOD_RES         10
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:10473631"
FT   MOD_RES         16
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:7775468"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDN2"
FT   MOD_RES         23
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:7775468,
FT                   ECO:0000269|PubMed:9435504"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         47
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         228
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         260
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDN2"
FT   MOD_RES         452
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         484
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         542
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P05023"
FT   MOD_RES         661
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDN2"
FT   MOD_RES         668
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDN2"
FT   MOD_RES         675
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDN2"
FT   MOD_RES         943
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:9435504"
FT   MUTAGEN         16
FT                   /note="S->A: Dopamine fails to increase phosphoinositide-3
FT                   kinase activity and to promote its interaction with
FT                   Na(+)/K(+) ATPase."
FT                   /evidence="ECO:0000269|PubMed:10823893"
FT   MUTAGEN         83
FT                   /note="P->R: Dopamine fails to increase phosphoinositide-3
FT                   kinase activity and to promote its interaction with
FT                   Na(+)/K(+) ATPase."
FT                   /evidence="ECO:0000269|PubMed:10823893"
FT   MUTAGEN         302
FT                   /note="L->R: Results in altered sodium and potassium
FT                   transport."
FT                   /evidence="ECO:0000269|PubMed:30388404"
FT   MUTAGEN         303
FT                   /note="G->R: Results in altered sodium and potassium
FT                   transport."
FT                   /evidence="ECO:0000269|PubMed:30388404"
FT   MUTAGEN         314
FT                   /note="E->K: Abolishes targeting to the basolateral plasma
FT                   membrane."
FT                   /evidence="ECO:0000269|PubMed:16914892"
FT   MUTAGEN         859
FT                   /note="M->R: Results in altered sodium and potassium
FT                   transport."
FT                   /evidence="ECO:0000269|PubMed:30388404"
FT   CONFLICT        68..69
FT                   /note="AA -> PV (in Ref. 3; AAA41671)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        175
FT                   /note="G -> E (in Ref. 3; AAA41671)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        188
FT                   /note="G -> V (in Ref. 3; AAA41671)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        335
FT                   /note="G -> V (in Ref. 3; AAA41671)"
FT                   /evidence="ECO:0000305"
FT   STRAND          394..396
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   STRAND          403..405
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   HELIX           416..427
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   STRAND          431..435
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   STRAND          438..440
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   HELIX           442..444
FT                   /evidence="ECO:0007829|PDB:1MO8"
FT   STRAND          447..449
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   TURN            451..453
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   HELIX           454..461
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   TURN            462..464
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   HELIX           467..473
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   STRAND          478..480
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   TURN            483..485
FT                   /evidence="ECO:0007829|PDB:1MO8"
FT   STRAND          489..494
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   STRAND          496..500
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   STRAND          502..509
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   HELIX           511..515
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   STRAND          518..521
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   STRAND          526..529
FT                   /evidence="ECO:0007829|PDB:1MO8"
FT   HELIX           532..546
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   STRAND          556..558
FT                   /evidence="ECO:0007829|PDB:1MO8"
FT   TURN            562..564
FT                   /evidence="ECO:0007829|PDB:1MO7"
FT   TURN            572..574
FT                   /evidence="ECO:0007829|PDB:1MO7"
SQ   SEQUENCE   1023 AA;  113054 MW;  85E98233EE6C18E9 CRC64;
     MGKGVGRDKY EPAAVSEHGD KKSKKAKKER DMDELKKEVS MDDHKLSLDE LHRKYGTDLS
     RGLTPARAAE ILARDGPNAL TPPPTTPEWV KFCRQLFGGF SMLLWIGAIL CFLAYGIRSA
     TEEEPPNDDL YLGVVLSAVV IITGCFSYYQ EAKSSKIMES FKNMVPQQAL VIRNGEKMSI
     NAEDVVVGDL VEVKGGDRIP ADLRIISANG CKVDNSSLTG ESEPQTRSPD FTNENPLETR
     NIAFFSTNCV EGTARGIVVY TGDRTVMGRI ATLASGLEGG QTPIAEEIEH FIHLITGVAV
     FLGVSFFILS LILEYTWLEA VIFLIGIIVA NVPEGLLATV TVCLTLTAKR MARKNCLVKN
     LEAVETLGST STICSDKTGT LTQNRMTVAH MWFDNQIHEA DTTENQSGVS FDKTSATWFA
     LSRIAGLCNR AVFQANQENL PILKRAVAGD ASESALLKCI EVCCGSVMEM REKYTKIVEI
     PFNSTNKYQL SIHKNPNASE PKHLLVMKGA PERILDRCSS ILLHGKEQPL DEELKDAFQN
     AYLELGGLGE RVLGFCHLLL PDEQFPEGFQ FDTDEVNFPV DNLCFVGLIS MIDPPRAAVP
     DAVGKCRSAG IKVIMVTGDH PITAKAIAKG VGIISEGNET VEDIAARLNI PVNQVNPRDA
     KACVVHGSDL KDMTSEELDD ILRYHTEIVF ARTSPQQKLI IVEGCQRQGA IVAVTGDGVN
     DSPALKKADI GVAMGIVGSD VSKQAADMIL LDDNFASIVT GVEEGRLIFD NLKKSIAYTL
     TSNIPEITPF LIFIIANIPL PLGTVTILCI DLGTDMVPAI SLAYEQAESD IMKRQPRNPK
     TDKLVNERLI SMAYGQIGMI QALGGFFTYF VILAENGFLP FHLLGIRETW DDRWINDVED
     SYGQQWTYEQ RKIVEFTCHT AFFVSIVVVQ WADLVICKTR RNSVFQQGMK NKILIFGLFE
     ETALAAFLSY CPGMGAALRM YPLKPTWWFC AFPYSLLIFV YDEVRKLIIR RRPGGWVEKE
     TYY
//
